Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo

被引:182
|
作者
Kurash, Julia K. [1 ]
Lei, Hong [2 ]
Shen, Qiong [1 ]
Marston, Wendy L. [2 ]
Granda, Brian W. [1 ]
Fan, Hong [1 ]
Wall, Daniel [1 ]
Li, En [1 ,2 ]
Gaudet, Francois [1 ]
机构
[1] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[2] Novartis Inst Biomed Res, Models Dis Ctr, Cambridge, MA 02139 USA
关键词
D O I
10.1016/j.molcel.2007.12.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein methyltransferase Set7/9 was recently shown to regulate p53 activity in cancer cells. However, the impact of Set7/9 on p53 function in vivo is unclear. To explore these issues, we created a null allele of Set7/9 in mice. Cells from Set7/9 mutant mice fail to methylate p53 K369, are unable to induce p53 downstream targets upon DNA damage, and are predisposed to oncogenic transformation. Importantly, we find that methylation of p53 by Set7/9 is required for the binding of the acetyltransferase Tip60 to p53 and for the subsequent acetylation of p53. We provide the first genetic evidence demonstrating that lysine methylation of p53 by Set7/9 is important for p53 activation in vivo and suggest a mechanistic link between methylation and acetylation of p53 through Tip60.
引用
收藏
页码:392 / 400
页数:9
相关论文
共 50 条
  • [31] TRANSACTIVATION OF P53 IN P53 MUTANT-CELL LINES IN-VIVO
    PARK, DJ
    NAKAMURA, H
    CHUMAKOV, AM
    SAID, JW
    MILLER, CW
    CHEN, DL
    KOEFFLER, HP
    BLOOD, 1993, 82 (10) : A39 - A39
  • [32] The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
    Huang, Lei
    Yan, Zheng
    Liao, Xiaodong
    Li, Yuan
    Yang, Jie
    Wang, Zhu-Gang
    Zuo, Yong
    Kawai, Hidehiko
    Shadfan, Miriam
    Ganapathy, Suthakar
    Yuan, Zhi-Min
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12001 - 12006
  • [33] p53 isoform Δ113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish
    Chen, Jun
    Ng, Sok Meng
    Chang, Changqing
    Zhang, Zhenhai
    Bourdon, Jean-Christophe
    Lane, David P.
    Peng, Jinrong
    GENES & DEVELOPMENT, 2009, 23 (03) : 278 - 290
  • [34] p53 isoforms change p53 paradigm
    Bourdon, J. C.
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (04):
  • [35] DNAJB9, a novel target gene of p53, binds to p53 and inhibits the transcriptional activity
    Heo, Jee In
    Lee, Mi-Suk
    Choi, Eun-Mi
    Jeong, Yu-Jin
    Kim, Jun-Kyung
    Lee, Sam W.
    Han, Jeong A.
    Kim, Jong-Il
    FASEB JOURNAL, 2007, 21 (05): : A661 - A661
  • [36] The impact of acetylation and deacetylation on the p53 pathway
    Christopher LBrooks
    Wei Gu
    Protein & Cell, 2011, 2 (06) : 456 - 462
  • [37] p53 activity and chemotherapy
    Delia, D
    Mizutani, S
    Lamorte, G
    Goi, K
    Iwata, S
    Pierotti, MA
    NATURE MEDICINE, 1996, 2 (07) : 724 - 725
  • [38] The regulation of radiosensitivity by p53 and its acetylation
    Zhang, Jing
    Shen, Liangfang
    Sun, Lun-Quan
    CANCER LETTERS, 2015, 363 (02) : 108 - 118
  • [39] P53 regulation and activity
    Meek, David W.
    TOXICOLOGY, 2007, 240 (03) : 133 - 134
  • [40] Restoring p53 activity
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (06) : 394 - 394